NEW: We've expanded Stock Detail, Screener, and Maps with new data

Stock Detail, Screener:
3, 5, 10-Year Performance
EV/EBITDA, EV/Sales
Dividend Growth (1, 3, 5 Years)
EPS & Sales Growth (3 Years)

Maps:
All from Screener plus:
ROA, ROE, ROIC
Quick & Current Ratios
LT Debt and Debt to Equity Ratios
Gross, Operating, and Net Margins

EXAS

Exact Sciences Corp

Jul 11 • 04:00PM ET

51.91

Dollar change -1.41
Percentage change -2.64	%

Healthcare • Diagnostics & Research • USA • NASD

Peers: ILMN GH NTRA TXG DGX FLGT BIO QDEL MYGN CSTM

| Held by: VTI VB VXF VBK XBI FBT IWR VHT SCHM IWD

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-5.50	Insider Own	1.53%	Shs Outstand	188.59M	Perf Week	-2.72%
Market Cap	9.79B	Forward P/E	141.08	EPS next Y	0.37	Insider Trans	-0.11%	Shs Float	185.74M	Perf Month	-7.60%
Enterprise Value	11.55B	PEG	-	EPS next Q	-0.13	Inst Own	97.49%	Short Float	3.78%	Perf Quarter	14.09%
Income	-1019.84M	P/S	3.46	EPS this Y	90.85%	Inst Trans	1.21%	Short Ratio	2.37	Perf Half Y	-9.09%
Sales	2.83B	P/B	4.08	EPS next Y	171.91%	ROA	-16.87%	Short Interest	7.02M	Perf YTD	-7.62%
Book/sh	12.71	P/C	12.46	EPS next 5Y	-	ROE	-36.89%	52W High	72.83 -28.72%	Perf Year	17.74%
Cash/sh	4.17	P/FCF	50.44	EPS past 3/5Y	-17.13% -54.24%	ROIC	-20.82%	52W Low	39.97 29.87%	Perf 3Y	19.91%
Dividend Est.	-	EV/EBITDA	478.26	Sales past 3/5Y	16.01% 25.78%	Gross Margin	69.57%	Volatility	3.93% 4.01%	Perf 5Y	-41.68%
Dividend TTM	-	EV/Sales	4.08	EPS Y/Y TTM	-315.25%	Oper. Margin	-6.75%	ATR (14)	2.11	Perf 10Y	84.27%
Dividend Ex-Date	-	Quick Ratio	2.38	Sales Y/Y TTM	11.57%	Profit Margin	-36.06%	RSI (14)	44.34	Recom	1.43
Dividend Gr. 3/5Y	- -	Current Ratio	2.73	EPS Q/Q	10.37%	SMA20	-2.18%	Beta	0.94	Target Price	69.04
Payout	-	Debt/Eq	1.06	Sales Q/Q	10.86%	SMA50	-3.91%	Rel Volume	0.59	Prev Close	53.32
Employees	7000	LT Debt/Eq	1.04	Earnings	May 01 AMC	SMA200	-5.68%	Avg Volume	2.95M	Price	51.91
IPO	Jan 31, 2001	Option/Short	Yes / Yes	EPS/Sales Surpr.	-44.04% 2.63%	Trades		Volume	1,740,471	Change	-2.64%

Date	Action	Analyst	Rating Change	Price Target Change
Apr-10-25	Initiated	Mizuho	Outperform	$60
Mar-13-25	Initiated	RBC Capital Mkts	Sector Perform	$52
Jan-23-25	Initiated	Barclays	Overweight	$70
Aug-28-24	Initiated	Wells Fargo	Overweight	$75
Jun-27-24	Initiated	Scotiabank	Sector Outperform	$70
Jun-03-24	Resumed	Jefferies	Buy	$75
Jan-02-24	Upgrade	The Benchmark Company	Hold → Buy	$91
Dec-14-23	Initiated	Guggenheim	Buy	$90
Dec-13-23	Initiated	Wolfe Research	Outperform	$95
Oct-10-23	Upgrade	Piper Sandler	Neutral → Overweight	$90
Sep-28-23	Initiated	Bernstein	Outperform	$83
Aug-02-23	Downgrade	The Benchmark Company	Buy → Hold
May-10-23	Upgrade	Craig Hallum	Hold → Buy	$55 → $85
May-05-23	Initiated	UBS	Neutral	$73
Mar-09-23	Upgrade	Citigroup	Neutral → Buy	$70 → $90
Feb-10-23	Downgrade	Credit Suisse	Outperform → Neutral	$50 → $70
Jan-18-23	Downgrade	Raymond James	Outperform → Mkt Perform
Oct-19-22	Downgrade	Craig Hallum	Buy → Hold	$60 → $35
Aug-25-22	Initiated	Credit Suisse	Outperform	$55
Jun-03-22	Initiated	Piper Sandler	Neutral	$50

Show Previous Ratings

Jul-10-25 11:40AM	QGEN or EXAS: Which Is the Better Value Stock Right Now? (Zacks)
Jul-09-25 06:00AM	Exact Sciences Announces Medicare Coverage for Oncodetect Molecular Residual Disease Test in Colorectal Cancer (Business Wire)
Jul-07-25 12:00PM	What Makes Exact Sciences (EXAS) a New Buy Stock (Zacks)
09:45AM	Are You a Growth Investor? This 1 Stock Could Be the Perfect Pick (Zacks)
Jul-03-25 08:50AM	How to Boost Your Portfolio with Top Medical Stocks Set to Beat Earnings (Zacks)
08:11AM	Loading…
Jul-02-25 08:11AM	What's Fueling Tempus AI's Explosive Sales Growth? (Zacks)
Jun-30-25 07:35AM	Concerns Rise Over Exact Sciences Corp. (EXAS) Salesforce Reorganization Affecting Growth (Insider Monkey)
Jun-27-25 04:25PM	Gilead, Exact Jump After The Supreme Court Upholds A 'Cornerstone' Of Health Care (Investor's Business Daily)
Jun-26-25 04:14AM	The 5 Most Interesting Analyst Questions From Exact Sciences's Q1 Earnings Call (StockStory)
Jun-24-25 11:40AM	QGEN vs. EXAS: Which Stock Is the Better Value Option? (Zacks)
Jun-23-25 01:37AM	Exact Sciences Expands Oncodetect Validation, Unveils MRD Innovation Roadmap. (Insider Monkey)
Jun-20-25 08:41AM	Tempus AI's 89% Genomics Surge: Will the Momentum Keep Building? (Zacks)
Jun-19-25 09:45AM	Why This 1 Growth Stock Could Be a Great Addition to Your Portfolio (Zacks)
Jun-18-25 08:43PM	Analyst Report: Exact Sciences Corporation (Morningstar Research)
Jun-12-25 06:20AM	Should You Invest in the SPDR S&P Biotech ETF (XBI)? (Zacks)
11:36PM	Loading…
Jun-11-25 11:36PM	A Look Back at Immuno-Oncology Stocks' Q1 Earnings: Exact Sciences (NASDAQ:EXAS) Vs The Rest Of The Pack (StockStory)
Jun-09-25 08:42AM	Hologic Climbs 13% in a Month: How Should You Play the Stock? (Zacks)
Jun-05-25 11:30AM	CRISPR Therapeutics (CRSP) Up 11.1% Since Last Earnings Report: Can It Continue? (Zacks)
08:52AM	Should You Continue to Hold EXAS Sciences Stock in Your Portfolio? (Zacks)
Jun-04-25 05:31AM	Freenome posts pivotal liquid biopsy data as FDA filing nears completion (MedTech Dive)
May-28-25 06:05AM	Exact Sciences Announces Expanded Clinical Validation of the Oncodetect Test and Molecular Residual Disease Innovation Roadmap (Business Wire)
May-27-25 04:05PM	Exact Sciences to Participate in June Investor Conference (Business Wire)
May-22-25 05:05PM	Exact Sciences Highlights Innovations in Early Cancer Detection and Precision Oncology at ASCO 2025 (Business Wire)
May-20-25 07:40AM	Exact Sciences Corporation (EXAS) Slid on Fear of Competition (Insider Monkey)
May-19-25 07:38PM	Analyst Report: Exact Sciences Corporation (Morningstar Research)
May-16-25 06:29AM	EXAS Q1 Earnings Call: Outperformance Driven by Commercial Execution, New Products, and Margin Expansion (StockStory)
12:38AM	1 Healthcare Stock Worth Investigating and 2 to Ignore (StockStory)
May-14-25 04:51AM	2 Brilliant Stocks to Buy With $200 and Hold for 5 Years (Motley Fool)
May-12-25 10:00AM	Exact Sciences Earns 2025 Great Place To Work Certification (Business Wire)
08:44AM	Tariffs Dim Hologic's 2025 Expectations: Time to Reassess the Stock? (Zacks)
04:55AM	Loading…
May-07-25 04:55AM	Fidelity Select Health Care Portfolio Q1 2025 Commentary (Seeking Alpha)
May-05-25 12:55PM	Analyst Report: Exact Sciences Corporation (Morningstar Research)
May-02-25 12:52PM	Exact Sciences Q1 Earnings: Decent Quarter, But Growth Story Not Compelling (Seeking Alpha) +9.31%
12:51PM	Q1 2025 Exact Sciences Corp Earnings Call (Thomson Reuters StreetEvents)
07:28AM	EXAS Stock Up on Q1 Earnings & Revenue Beat, 2025 Sales View Raised (Zacks)
06:00AM	Exact Sciences to Participate in May Investor Conference (Business Wire)
03:18AM	Exact Sciences Corp (EXAS) Q1 2025 Earnings Call Highlights: Strong Revenue Growth and New ... (GuruFocus.com)
May-01-25 08:47PM	Exact Sciences Corporation (EXAS) Q1 2025 Earnings Call Transcript (Seeking Alpha)
05:35PM	Exact Sciences (EXAS) Reports Q1 Loss, Tops Revenue Estimates (Zacks)
04:36PM	Exact Sciences: Q1 Earnings Snapshot (Associated Press Finance)
04:05PM	Exact Sciences Hikes Its Full-Year Outlook. But There's One First-Quarter Drawback. (Investor's Business Daily)
04:05PM	Exact Sciences Announces First-Quarter 2025 Results (Business Wire)
Apr-30-25 08:50AM	These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar (Zacks)
Apr-29-25 06:59AM	Exact Sciences to Highlight Cologuard Test Adherence and Predicted Preference Data at Digestive Disease Week (DDW) 2025 (Business Wire)
Apr-28-25 10:00AM	Certara, Inc. (CERT) Earnings Expected to Grow: Should You Buy? (Zacks)
Apr-24-25 10:01AM	Exact Sciences (EXAS) Expected to Beat Earnings Estimates: What to Know Ahead of Q1 Release (Zacks)
08:08AM	Exact Sciences (EXAS): Among Billionaire George Soros' Small-Cap Stocks with Huge Upside Potential (Insider Monkey)
05:03AM	2 Reasons to Like EXAS (and 1 Not So Much) (StockStory)
Apr-23-25 08:50AM	Why Investors Need to Take Advantage of These 2 Medical Stocks Now (Zacks)
Apr-22-25 06:00AM	Exact Sciences Launches the Oncodetect Molecular Residual Disease Test (Business Wire)
Apr-17-25 04:15PM	The Blood Test Revolution: It's A New Day In Cancer. Guardant, Natera And Exact Are Here For It. (Investor's Business Daily)
Apr-15-25 05:02AM	Immuno-Oncology Stocks Q4 In Review: Exact Sciences (NASDAQ:EXAS) Vs Peers (StockStory)
Apr-14-25 03:00PM	Tap Into the Silver Economy Boom With These Aging Demographics Stocks (Zacks)
06:00AM	JAMA Oncology Publication Strengthens Evidence for Oncotype DX Test Reliability Across Racial and Ethnic Groups (Business Wire)
Apr-01-25 06:00AM	Exact Sciences Schedules First Quarter 2025 Earnings Call (Business Wire)
Mar-31-25 06:00AM	Exact Sciences Launches the Cologuard Plus Test, Transforming Colorectal Cancer Screening (Business Wire)
Mar-30-25 07:10AM	abrdn World Healthcare Fund Q4 2024 Commentary (Seeking Alpha)
03:25AM	abrdn Healthcare Opportunities Fund Q4 2024 Commentary (Seeking Alpha)
Mar-29-25 12:20AM	PGIM Jennison Mid-Cap Growth Fund Q4 2024 Commentary (Seeking Alpha)
Mar-27-25 09:06AM	Should You Retain Exact Sciences Stock in Your Portfolio Now? (Zacks)
Mar-26-25 11:10AM	Columbia Acorn Fund Q4 2024 Commentary (SeekingAlpha)
Mar-24-25 12:35PM	Why Exact Sciences Corporation (EXAS) is Among the Best Diagnostics Stocks to Invest in Right Now (InsiderMonkey)
Mar-21-25 11:30AM	Exact Sciences (EXAS) Down 10.6% Since Last Earnings Report: Can It Rebound? (Zacks)
Mar-20-25 09:03AM	1 Healthcare Stock on Our Watchlist and 2 to Turn Down (StockStory)
08:50AM	Should You Invest in Exact Sciences Corp. (EXAS)? (InsiderMonkey)
Mar-19-25 04:10PM	SERA PROGNOSTICS ANNOUNCES APPOINTMENT OF JEFF ELLIOTT TO ITS BOARD; RYAN TRIMBLE AND MARCUS WILSON TO STEP DOWN (PR Newswire)
Mar-14-25 09:01AM	1 Stock Under $50 to Target This Week and 2 to Turn Down (StockStory)
Mar-12-25 09:00AM	Exact Sciences Named 2025 Gallup Exceptional Workplace Award Winner (Business Wire)
Mar-04-25 09:00AM	Heres What Led Artisan Mid Cap Fund to Trim Exact Sciences Corporation (EXAS) (Insider Monkey)
Mar-03-25 06:48PM	Exact Sciences Corporation (EXAS): Among the Cash-Rich Mid Cap Stocks to Buy Now (Insider Monkey)
Feb-24-25 12:00PM	2 Stocks Down 59% and 34% to Buy and Hold (Motley Fool)
06:00AM	Exact Sciences to Participate in March Investor Conferences (Business Wire)
Feb-20-25 07:01PM	Analyst Report: Exact Sciences Corporation (Morningstar Research)
01:40PM	Why Exact Sciences (EXAS) Shares Are Trading Lower Today (StockStory)
08:25AM	Q4 2024 Exact Sciences Corp Earnings Call (Thomson Reuters StreetEvents)
02:12AM	Exact Sciences Corp (EXAS) Q4 2024 Earnings Call Highlights: Strong Revenue Growth and ... (GuruFocus.com)
12:30AM	Exact Sciences (EXAS) Q4 2024 Earnings Call Transcript (Motley Fool)
Feb-19-25 05:25PM	Exact Sciences (EXAS) Reports Q4 Loss, Tops Revenue Estimates (Zacks)
04:42PM	Exact Sciences: Q4 Earnings Snapshot (Associated Press Finance)
04:22PM	Exact Sciencess (NASDAQ:EXAS) Q4: Beats On Revenue (StockStory)
04:05PM	Exact Sciences Announces Fourth Quarter 2024 Results (Business Wire)
Feb-18-25 08:03AM	Exact Sciences (EXAS) Reports Earnings Tomorrow: What To Expect (StockStory)
Feb-12-25 05:57PM	Trickle-down effect of NIH funding battle worries healthcare analysts and medical experts (Yahoo Finance)
10:00AM	Exact Sciences (EXAS) Expected to Beat Earnings Estimates: Can the Stock Move Higher? (Zacks)
Feb-06-25 08:30AM	Dentsply Sirona Appoints Michael Barber and Daniel Scavilla as New Board Members (GlobeNewswire)
Feb-03-25 06:00AM	Exact Sciences Schedules Fourth Quarter 2024 Earnings Call (Business Wire)
Jan-22-25 07:39AM	Exact Sciences post positive results from MRD trial (Clinical Trials Arena)
Jan-21-25 05:05PM	New Evidence Validates Oncodetect's Ability to Detect Molecular Residual Disease and Predict Recurrence in Colorectal Cancer Patients (Business Wire)
05:05PM	Exact Sciences Demonstrates Leadership in Cancer Innovation with New Data on Screening and Molecular Residual Disease at 2025 ASCO GI Symposium (Business Wire)
04:03PM	Why Top 4% Guardant Health Surged To A 13-Month High And Topped A Profit-Taking Zone (Investor's Business Daily)
Jan-17-25 06:15AM	Why Exact Sciences (EXAS) Is Crashing? (Insider Monkey)
Jan-16-25 09:15PM	Analyst Report: Exact Sciences Corporation (Morningstar Research) -5.75%
04:05PM	Exact Sciences Stock Drops 11% Over Four Days. 'What Is Going On?' (Investor's Business Daily)
05:22AM	2 Healthcare Stocks to Buy Hand Over Fist in January (Motley Fool)
Jan-12-25 07:00PM	Exact Sciences Announces Preliminary Fourth Quarter 2024 Results (Business Wire)
Jan-03-25 06:46AM	Exact Sciences price target raised to $70 from $60 at Evercore ISI (TipRanks)
Jan-02-25 06:00AM	Exact Sciences to Participate in J.P. Morgan Healthcare Conference (Business Wire)
Nov-26-24 07:27PM	Analyst Report: Exact Sciences Corporation (Morningstar Research) +9.00%
01:24PM	Why Is Exact Sciences Stock Trading Higher On Tuesday? (CORRECTED) (Benzinga)
06:00AM	Exact Sciences to Participate in December Investor Conferences (Business Wire)

EXACT Sciences Corp. is a cancer screening and diagnostics company. The firm focuses on the early detection and prevention of some forms of cancer. It offers a non-invasive screening test called Cologuard for the early detection of colorectal cancer and pre-cancer and Oncotype DX. The company was founded on February 10, 1995, and is headquartered in Madison, WI.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Zanotti Katherine S	Director	Jun 13 '25	Sale	53.20	3,207	170,612	72,759	Jun 16 05:30 PM
Zanotti Katherine S	Director	Jun 13 '25	Proposed Sale	53.20	3,207	170,612		Jun 13 09:50 AM
Bloomer Aaron	EVP, Chief Financial Officer	Apr 15 '25	Option Exercise	0.00	24,460	0	19,340	Apr 17 04:30 PM
Conroy Kevin T	President and CEO	Mar 07 '25	Option Exercise	22.38	66,723	1,493,261	1,203,269	Mar 10 05:00 PM
Herriott James	SVP, General Counsel & Sec	Feb 28 '25	Option Exercise	0.00	4,265	0	16,339	Mar 04 04:48 PM
Conroy Kevin T	President and CEO	Feb 28 '25	Option Exercise	0.00	40,310	0	1,146,965	Mar 04 04:47 PM
Baranick Brian	EVP, GM, Precision Oncology	Feb 28 '25	Option Exercise	0.00	9,673	0	25,106	Mar 04 04:44 PM
ORVILLE JACOB A	EVP, GM, Screening	Feb 28 '25	Option Exercise	0.00	9,673	0	27,728	Mar 04 04:40 PM
Condella Sarah	EVP, Human Resources	Feb 28 '25	Option Exercise	0.00	7,738	0	84,399	Mar 04 04:37 PM
Condella Sarah	EVP, Human Resources	Feb 25 '25	Option Exercise	0.00	3,954	0	80,297	Feb 26 08:00 PM
Baranick Brian	EVP, GM, Precision Oncology	Feb 25 '25	Option Exercise	0.00	3,954	0	19,841	Feb 26 08:00 PM
Herriott James	SVP, General Counsel & Sec	Feb 25 '25	Option Exercise	0.00	1,647	0	13,738	Feb 26 08:00 PM
ORVILLE JACOB A	EVP, GM, Screening	Feb 25 '25	Option Exercise	0.00	3,954	0	22,136	Feb 26 08:00 PM
Conroy Kevin T	President and CEO	Feb 25 '25	Option Exercise	0.00	13,180	0	1,121,378	Feb 26 08:00 PM
Conroy Kevin T	President and CEO	Feb 19 '25	Option Exercise	0.00	10,374	0	1,084,565	Feb 21 04:30 PM
COWARD D SCOTT	Director	Feb 19 '25	Option Exercise	0.00	2,248	0	52,831	Feb 21 04:30 PM
ORVILLE JACOB A	EVP, GM, Screening	Feb 19 '25	Option Exercise	0.00	2,248	0	16,688	Feb 21 04:30 PM
Baranick Brian	EVP, GM, Precision Oncology	Feb 19 '25	Option Exercise	0.00	1,729	0	14,487	Feb 21 04:30 PM
Condella Sarah	EVP, Human Resources	Feb 19 '25	Option Exercise	0.00	2,248	0	74,859	Feb 21 04:30 PM
Herriott James	SVP, General Counsel & Sec	Feb 19 '25	Option Exercise	0.00	865	0	10,731	Feb 21 04:30 PM
Conroy Kevin T	President and CEO	Nov 13 '24	Buy	51.35	19,500	1,001,325	1,074,191	Nov 13 12:56 PM
Baranick Brian	EVP, GM, Precision Oncology	Oct 08 '24	Sale	70.00	929	65,030	12,758	Oct 09 05:00 PM
Baranick Brian	Officer	Oct 08 '24	Proposed Sale	70.00	929	65,030		Oct 08 01:27 PM
Baranick Brian	EVP, GM, Precision Oncology	Sep 18 '24	Sale	70.00	929	65,030	13,687	Sep 19 05:00 PM
Baranick Brian	Officer	Sep 18 '24	Proposed Sale	70.00	929	65,030		Sep 18 04:15 PM
Baranick Brian	EVP, GM, Precision Oncology	Aug 05 '24	Option Exercise	0.00	2,712	0	15,991	Aug 06 05:30 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

EXAS

Exact Sciences Corp

Upgrade your FINVIZ experience